EA
LFCR icon

Emerald Acquisition’s Lifecore Biomedical LFCR Stock Holding History

Emerald Acquisition’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.75M Sell
205,229
-99,867
-33% -$1.21M 0.01% 1574
2016
Q2 		$3.28M Buy
+305,096
New +$3.37M 0.01% 1587

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Emerald Acquisition's LFCR Position: Q3 2016 in Review

Emerald Acquisition reduced its Lifecore Biomedical (LFCR) stake by 33% in Q3 2016, selling an estimated $1.21M and leaving 205,229 shares worth $2.75M. The position accounts for 0.01% of the portfolio, ranked #1574.

Emerald Acquisition first reported a position in LFCR in Q2 2016 and has held it in 2 quarters since. The position peaked at $3.28M in Q2 2016. 93 funds tracked by Wall St. Rank hold LFCR as of Q3 2016.

  • Emerald Acquisition held 205,229 shares of Lifecore Biomedical worth $2.75M as of Q3 2016.
  • Emerald Acquisition sold 99,867 Lifecore Biomedical shares in Q3 2016, an estimated $1.21M.
  • Lifecore Biomedical made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1574 holding.
  • Emerald Acquisition first reported a position in Lifecore Biomedical in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Lifecore Biomedical position peaked at $3.28M in Q2 2016.
  • 93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.